Epigenetic markers have been extensively employed to identify several physiological and/or pathological conditions, as they are associated with a long list of biological processes, including DNA methylation, histone modifications, genomic imprinting, and regulation of protein-coding mRNAs mediated by microRNAs (miRNAs). miRNAs are small noncoding RNAs (15–25 nucleotides in length) able to bind the 3′UTR and, less frequently, 5′UTR and coding sequences (CDS) of target mRNAs leading to mRNA-translation repression and/or mRNA degradation, depending on binding affinity. Recently, miRNAs have been extensively investigated as epigenetic biomarkers for the identification of physiological alterations, such as doping-related procedures, thanks to their easily detection and stability in a large variety of body fluids including bloods and derivatives (plasma and serum). As for several physiological alterations, it is expected that the miRNA expression profile may be altered following the exposure to agents employed in doping procedures. In agreement with this hypothesis circulating miRNAs were found to be associated with administration of human testosterone and growth-hormone and have been proposed as long-term biomarkers for the detection of the erythropoiesis-stimulating agent CERA. Hypoxia-regulated miRNAs might be used to identify the HIF Stabilizer Molidustat. In addition, despite the occurrence of possible confounding factors (changes in the miRNA expression profile during blood storage, aging, exercise, environment), miRNAs have been proposed as potential markers of autologous blood transfusion in sports.

Epigenetics and doping in sports—The role of microRNAs

Gambari, Roberto
Primo
;
Gasparello, Jessica
Secondo
;
Lamberti, Nicola;Manfredini, Fabio;Finotti, Alessia
Ultimo
2021

Abstract

Epigenetic markers have been extensively employed to identify several physiological and/or pathological conditions, as they are associated with a long list of biological processes, including DNA methylation, histone modifications, genomic imprinting, and regulation of protein-coding mRNAs mediated by microRNAs (miRNAs). miRNAs are small noncoding RNAs (15–25 nucleotides in length) able to bind the 3′UTR and, less frequently, 5′UTR and coding sequences (CDS) of target mRNAs leading to mRNA-translation repression and/or mRNA degradation, depending on binding affinity. Recently, miRNAs have been extensively investigated as epigenetic biomarkers for the identification of physiological alterations, such as doping-related procedures, thanks to their easily detection and stability in a large variety of body fluids including bloods and derivatives (plasma and serum). As for several physiological alterations, it is expected that the miRNA expression profile may be altered following the exposure to agents employed in doping procedures. In agreement with this hypothesis circulating miRNAs were found to be associated with administration of human testosterone and growth-hormone and have been proposed as long-term biomarkers for the detection of the erythropoiesis-stimulating agent CERA. Hypoxia-regulated miRNAs might be used to identify the HIF Stabilizer Molidustat. In addition, despite the occurrence of possible confounding factors (changes in the miRNA expression profile during blood storage, aging, exercise, environment), miRNAs have been proposed as potential markers of autologous blood transfusion in sports.
2021
9780128206829
Autologous blood transfusion (ABT), Doping, MicroRNA, Plasma, Liquid biopsy
File in questo prodotto:
File Dimensione Formato  
Book Antidoping 2021.pdf

solo gestori archivio

Descrizione: Articolo principale
Tipologia: Full text (versione editoriale)
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 18.88 MB
Formato Adobe PDF
18.88 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2479105
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact